The Violence Epidemic in the African American Community: A Call by the National Medical Association for Comprehensive Reform
While much progress has occurred since the civil rights act of 1964, minorities have continued to suffer disparate and discriminatory access to economic opportunities, education, housing, health care and criminal justice. The latest challenge faced by the physicians and public health providers who serve the African American community is the detrimental, and seemingly insurmountable, causes and effects of violence in impoverished communities of color.
Sierra Leone Contains New Threat of Ebola with Lessons Learned
Source: USAID Date: March 21, 2016
WEST AFRICA - EBOLA OUTBREAK FACT SHEET #9
Source: USAID and CDC Date: March 24, 2016
Ebola Facts, Information, and FAQ
In response to the Ebola public health emergency, a number of public health agencies and organizations including the Centers for Disease Control and Prevention (CDC), have provided Ebola education materials. This link contains links to information from creditable sources that would be useful to healthcare providers and institutions right now.
NMA Joins Letter to FDA Commissioner Regarding Proposed Rule on Generic Labeling
On September 30, 2014, the NMA joined other leading African-American and Hispanic community and health care organizations in submitting a letter to the Food and Drug Administration (FDA) raising concerns that its Proposed Rule on Generic Labeling could jeopardize patient safety and access to affordable medicines. The letter focused on the adverse consequences of the proposed rule on patients, on costs, and on vulnerable populations.
NMA Participates in Effort Requesting CMS to Provide Medicare Coverage for LDCT Lung Cancer Screening
On September 26, 2014, NMA participated with other leading medical organizations by signing a letter to the Centers for Medicare & Medicaid Services (CMS) to support full Medicare coverage for annual low-dose computed tomography (LDCT) scans as a screening modality in adults ages 55 to 80 years, who have a 30 pack-year or greater smoking history and currently smoke or have quit within the past 15 years. This was further supported by the December 2013 United States Preventative Services Task Force’s (USPSTP) Grade B recommendation. Lung cancer screening with LDTC is not only cost effective as a screening tool, but is the only diagnostic procedure proven to reduce mortality from lung cancer in individuals who are at high-risk for development of lung cancer. Private insurers are required to cover any service receiving a grade A or B recommendation from the USPSTF according to the Affordable Care Act; however, this requirement does not apply to and is not relevant to Medicare coverage.